Variant report
Variant | esv3346493 |
---|---|
Chromosome Location | chr10:53862415-53869874 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191588096 | chr10:53862424-53862425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548253304 | chr10:53862433-53862434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146739501 | chr10:53862512-53862513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182562094 | chr10:53862527-53862528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185282462 | chr10:53862531-53862532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537367507 | chr10:53862535-53862536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140309531 | chr10:53862577-53862578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562071551 | chr10:53862633-53862634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377104335 | chr10:53862650-53862651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189811138 | chr10:53862785-53862786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117390747 | chr10:53862791-53862792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150364626 | chr10:53862813-53862814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539569151 | chr10:53862839-53862840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530922300 | chr10:53862892-53862893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182102334 | chr10:53862920-53862921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544757629 | chr10:53862929-53862930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12414927 | chr10:53862934-53862935 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs34528822 | chr10:53862952-53862953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530980163 | chr10:53862960-53862961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12412155 | chr10:53862970-53862971 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs138100196 | chr10:53863027-53863028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543526657 | chr10:53863048-53863049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533723908 | chr10:53863059-53863060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370366772 | chr10:53863129-53863130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149448941 | chr10:53863131-53863132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78213193 | chr10:53863199-53863200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75599058 | chr10:53863227-53863228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532660505 | chr10:53863272-53863273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10824038 | chr10:53863292-53863293 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs571429238 | chr10:53863307-53863308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553727755 | chr10:53863366-53863367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145804528 | chr10:53863496-53863497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs72803136 | chr10:53863534-53863535 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs11000791 | chr10:53863539-53863540 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs536127718 | chr10:53863552-53863553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573546278 | chr10:53863553-53863554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575293883 | chr10:53863656-53863657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572480671 | chr10:53863713-53863714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142403838 | chr10:53863746-53863747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189202999 | chr10:53863760-53863761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs71485790 | chr10:53863762-53863763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs374500505 | chr10:53863768-53863769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs545999470 | chr10:53863769-53863770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs74673449 | chr10:53863770-53863771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531427052 | chr10:53863771-53863772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529573601 | chr10:53863772-53863773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34772697 | chr10:53863778-53863779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs59186791 | chr10:53863784-53863785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs533592121 | chr10:53863785-53863786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557921026 | chr10:53863802-53863803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Dysmorphic features | 21948486 | CNVD |
Epilepsy | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:53854800-53866600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr10:53856400-53866200 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr10:53860000-53865600 | Weak transcription | Aorta | Aorta |
4 | chr10:53861600-53862600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr10:53862200-53866600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
6 | chr10:53865800-53867000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
7 | chr10:53865800-53869600 | Weak transcription | Aorta | Aorta |
8 | chr10:53866000-53870200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
9 | chr10:53866200-53867000 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr10:53866600-53867000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
11 | chr10:53866600-53867000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr10:53866600-53867000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr10:53866600-53867200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr10:53866600-53867400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr10:53867000-53869600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
16 | chr10:53867000-53872400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
17 | chr10:53867200-53869600 | Weak transcription | Psoas Muscle | Psoas |
18 | chr10:53869600-53869800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
19 | chr10:53869600-53870000 | Enhancers | Psoas Muscle | Psoas |
20 | chr10:53869800-53870200 | Weak transcription | Skeletal Muscle Male | skeletal muscle |